Recombinant Human Anti-PD1 x Human Anti-TIM-3 Bispecific Antibody (scFv-CH1/CL) (BSCC-H348)

Recombinant Anti-PD1 x Anti-TIM-3 Bispecific Antibody (scFv-CH1/CL) is designed to be expressed as two chains. One scFv from an anti-PD1 antibody variable domain is fused to CH1 and the other scFv from an anti-TIM-3 antibody variable domain fused to CL, or vice versa. And the CH1 and CL domains are linked covalently via a natural disulfide bond. This BsAb can bind two receptors simultaneously and target unresponsive immune cells. It is designed for the research of Cancers therapy.

Datasheet INQUIRY

Specifications

Targets

PD1 & TIM-3

Type

scFv-based Bispecific Fragments

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Cancers

Targets

Target 1

PD1

Gene ID

5133

UniProt ID

Q15116

Alternative Names

PDCD1; programmed cell death 1; PD1; PD-1; CD279; SLEB2; hPD-1; hPD-l; hSLE1; programmed cell death protein 1; protein PD-1; systemic lupus erythematosus susceptibility 2

Target 2

TIM-3

Gene ID

84868

UniProt ID

Q8TDQ0

Alternative Names

TIM3; CD366; KIM-3; TIMD3; Tim-3; TIMD-3; HAVcr-2; T cell immunoglobulin and mucin domain 3; HAVCR2; hepatitis A virus cellular receptor 2

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Human Anti-PD1 x Human Anti-TIM-3 Bispecific Antibody (scFv-CH1/CL) (BSCC-H348). Click the button below to contact us or submit your feedback about this product.

Recombinant Human Anti-PD1 x Human Anti-TIM-3 Bispecific Antibody (scFv-CH1/CL) (CAT#: BSCC-H348)

Specifications

Targets

Customer Reviews and Q&As